Straumann Holding AG (OTCMKTS:SAUHY) Short Interest Update

Straumann Holding AG (OTCMKTS:SAUHY) was the recipient of a significant decline in short interest in the month of December. As of December 15th, there was short interest totaling 3,073 shares, a decline of 80.1% from the November 30th total of 15,433 shares. Approximately 0.0% of the company’s shares are short sold. Based on an average daily volume of 282,575 shares, the days-to-cover ratio is currently 0.0 days. Based on an average daily volume of 282,575 shares, the days-to-cover ratio is currently 0.0 days. Approximately 0.0% of the company’s shares are short sold.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on SAUHY shares. Morgan Stanley reissued an “underweight” rating on shares of Straumann in a research report on Monday, December 15th. Deutsche Bank Aktiengesellschaft upgraded Straumann from a “hold” rating to a “buy” rating in a report on Friday, October 31st. The Goldman Sachs Group downgraded Straumann from a “strong-buy” rating to a “neutral” rating in a report on Monday, October 13th. Citigroup reaffirmed a “sell” rating on shares of Straumann in a research report on Wednesday, October 22nd. Finally, UBS Group raised shares of Straumann from a “sell” rating to a “neutral” rating in a research report on Tuesday, November 4th. Two investment analysts have rated the stock with a Strong Buy rating, one has assigned a Buy rating, two have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold”.

Straumann Stock Performance

OTCMKTS SAUHY opened at $11.70 on Thursday. Straumann has a 52 week low of $10.30 and a 52 week high of $15.07. The stock’s 50 day moving average price is $11.79 and its two-hundred day moving average price is $12.07.

About Straumann

Straumann (OTCMKTS:SAUHY) is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company’s core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.

In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows.